Your browser doesn't support javascript.
loading
Ligelizumab in adolescents with chronic spontaneous urticaria: Results of a dedicated phase 2b randomized clinical trial supported with pharmacometric analysis.
Staubach, Petra; Alvaro-Lozano, Montserrat; Sekerel, Bulent Enis; Maurer, Marcus; Ben-Shoshan, Moshe; Porter, Miriam; Hua, Eva; Ji, Yan; Burciu, Alis; Savelieva, Marina; Severin, Thomas; Drollmann, Anton; Bienczak, Andrzej.
Affiliation
  • Staubach P; Department of Dermatology, University Medical Center, Mainz, Germany.
  • Alvaro-Lozano M; Department of Pediatric Allergology and Clinical Immunology, Hospital Sant Joan de Déu, Esplugues (Barcelona), Institut de Recerca Sant Joan de Déu, Universitat de Barcelona, Barcelona, Spain.
  • Sekerel BE; Faculty of Medicine, Pediatric Allergy and Asthma Unit, Hacettepe University, Ankara, Turkey.
  • Maurer M; Institute of Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Ben-Shoshan M; Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Allergology and Immunology, Berlin, Germany.
  • Porter M; Division of Allergy and Clinical Immunology, Department of Paediatrics, Montreal Children's Hospital McGill University Health Centre, Montreal, Quebec, Canada.
  • Hua E; Novartis Pharma AG, Basel, Switzerland.
  • Ji Y; Shanghai Novartis Trading Ltd., Shanghai, China.
  • Burciu A; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA.
  • Savelieva M; Novartis Pharma AG, Basel, Switzerland.
  • Severin T; Novartis Pharma AG, Basel, Switzerland.
  • Drollmann A; Novartis Pharma AG, Basel, Switzerland.
  • Bienczak A; Novartis Pharma AG, Basel, Switzerland.
Pediatr Allergy Immunol ; 34(7): e13982, 2023 07.
Article in En | MEDLINE | ID: mdl-37492920

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urticaria / Anti-Allergic Agents / Chronic Urticaria Type of study: Clinical_trials / Prognostic_studies Aspects: Patient_preference Limits: Adolescent / Adult / Child / Humans Language: En Journal: Pediatr Allergy Immunol Journal subject: ALERGIA E IMUNOLOGIA / PEDIATRIA Year: 2023 Document type: Article Affiliation country: Germany

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urticaria / Anti-Allergic Agents / Chronic Urticaria Type of study: Clinical_trials / Prognostic_studies Aspects: Patient_preference Limits: Adolescent / Adult / Child / Humans Language: En Journal: Pediatr Allergy Immunol Journal subject: ALERGIA E IMUNOLOGIA / PEDIATRIA Year: 2023 Document type: Article Affiliation country: Germany